Serina Therapeutics Inc. (SER)
NYSE: SER
· Real-Time Price · USD
5.28
-0.22 (-4.00%)
At close: Aug 15, 2025, 3:59 PM
5.40
2.27%
After-hours: Aug 15, 2025, 04:10 PM EDT
Serina Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 130K | 51K | 56K | 3.14M | 3.19M | 3.15M | 3.15M | 94K | 36K | 39K | 34K | 28K | 43K | 68K | 119K | 622K | 1.03M | 1.41M |
Cost of Revenue | 73K | 130K | 138K | 91K | 101K | 81K | 90K | 171K | 143K | 145K | 145K | 145K | 141K | 148K | 150K | 731K | 1.12M | 1.48M |
Gross Profit | -129K | -135K | -138K | 3.01M | 3.06M | 3.03M | 3.03M | -77K | -107K | -106K | -111K | -117K | -98K | -80K | -31K | -109K | -85K | -66K |
Operating Income | -22.28M | -20.59M | -17.05M | -11.26M | -7.41M | -5.43M | -5.27M | -7.29M | -7.38M | -7.08M | -6.97M | -7.08M | -7.21M | -7.82M | -8.06M | -8.62M | -9.35M | -9.77M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -12.64M | -1.01M | -5.63M | -1.83M | -1.46M | -9.31M | -3.16M | -6.97M | -11.16M | -11.1M | -10.52M | -9.92M | -9.44M | -9.3M | -8.58M | -9.03M | -9.64M | -9.9M |
Net Income | -12.59M | -939K | -5.56M | -6.28M | -13.09M | -20.96M | -14.8M | -14.05M | -11.08M | -11.03M | -10.46M | -9.92M | -9.44M | -9.29M | -8.68M | -8.96M | -9.55M | -9.77M |
Selling & General & Admin | 11.53M | 11.31M | 9.62M | 8.39M | 7.65M | 7.06M | 7.83M | 7.48M | 6.7M | 6.3M | 5.97M | 5.91M | 5.94M | 6.35M | 6.71M | 6.48M | 6.78M | 6.46M |
Research & Development | 10.88M | 9.32M | 7.48M | 6.02M | 3.79M | 2.32M | 1.36M | 629K | 573K | 671K | 893K | 1.06M | 1.18M | 1.4M | 1.32M | 2.03M | 2.48M | 3.25M |
Other Expenses | n/a | -51K | -74K | -94K | -80K | -29K | -6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 22.41M | 20.59M | 17.03M | 14.32M | 11.36M | 9.36M | 9.19M | 8.11M | 7.27M | 6.97M | 6.86M | 6.97M | 7.11M | 7.74M | 8.03M | 8.51M | 9.26M | 9.7M |
Interest Expense | 24K | 275K | 374K | 533K | 617K | 570.7K | 557.7K | 1.36M | 2.18M | 2.85M | 3.88M | 3.2M | 2.56M | 1.97M | 1.1M | 1.01M | 877K | 690K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 1.28M | 2.54M | 3.94M | 3.94M | 2.66M | 1.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.72M | 20.64M | 17.1M | 11.35M | 8.46M | 6.43M | 6.28M | 8.28M | 7.41M | 7.12M | 7.01M | 7.11M | 7.25M | 7.89M | 8.18M | 9.24M | 10.38M | 11.18M |
Income Tax Expense | n/a | n/a | n/a | -2K | -2K | -12K | -20K | -18K | -19K | -9K | -2K | -3K | -2K | -3K | -2K | -151K | -151K | -150K |
Shares Outstanding (Basic) | 10M | 9.76M | 8.85M | 8.85M | 8.51M | 2.79M | 1.08M | 2.19M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.07M |
Shares Outstanding (Diluted) | 10M | 9.76M | 10.75M | 10.75M | 10.16M | 2.79M | 1.08M | 7.58M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.07M |
EPS (Basic) | -1.3 | -0.03 | -2.92 | -5.81 | -5.17 | -8.25 | -7.91 | -7.22 | -10.28 | -10.24 | -9.71 | -9.2 | -8.75 | -8.61 | -8.05 | -8.33 | -8.89 | -9.11 |
EPS (Diluted) | -1.27 | -0.1 | -2.99 | -5.94 | -5.84 | -8.82 | -8.48 | -7.79 | -10.28 | -10.24 | -9.71 | -9.2 | -8.75 | -8.61 | -8.05 | -8.33 | -8.89 | -9.11 |
EBITDA | -11.59M | -553K | -5.06M | -1.15M | -698K | -8.03M | -868K | -3.85M | -7.27M | -7.14M | -7.01M | -7.12M | -7.24M | -7.69M | -7.39M | -7.35M | -7.75M | -7.86M |
EBIT | -6.16M | -739K | -5.25M | -1.29M | -840K | -5.34M | 5.74M | 2.73M | -636K | -3.31M | -6.64M | -6.72M | -6.88M | -7.33M | -7.49M | -8.02M | -8.76M | -9.21M |
Depreciation & Amortization | 129K | 186K | 194K | 144K | 142K | 117K | 125K | 152K | 131K | 132K | 132K | 132K | 131K | 131K | 131K | 675K | 1.01M | 1.35M |